IL24 and cancer: Initial studies in a Phase I clinical trial in patients with advanced cancers confirmed that intratumoral injection of an adenovirus (Ad) expressing mda-7/IL-24 (Ad.mda-7; INGN 241) is safe and clinically effective in inducing cancer cell-specific apoptosis.